Cargando…
Author Correction: Combination of sphingosine-1-phosphate receptor 1 (S1PR1) agonist and antiviral drug: a potential therapy against pathogenic influenza virus
Autores principales: | Zhao, Jiangnan, Zhu, Meiying, Jiang, Hao, Shen, Simen, Su, Xin, Shi, Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7385484/ https://www.ncbi.nlm.nih.gov/pubmed/32719379 http://dx.doi.org/10.1038/s41598-020-69835-w |
Ejemplares similares
-
RETRACTED ARTICLE: Combination of sphingosine-1-phosphate receptor 1 (S1PR1) agonist and antiviral drug: a potential therapy against pathogenic influenza virus
por: Zhao, Jiangnan, et al.
Publicado: (2019) -
Retraction Note: Combination of sphingosine-1-phosphate receptor 1 (S1PR1) agonist and antiviral drug: a potential therapy against pathogenic influenza virus
por: Zhao, Jiangnan, et al.
Publicado: (2023) -
Author Correction: Defective Sphingosine-1-phosphate metabolism is a druggable target in Huntington’s disease
por: Di Pardo, Alba, et al.
Publicado: (2018) -
Correction: Sphingosine-1-Phosphate Enhances Satellite Cell Activation in Dystrophic Muscles through a S1PR2/STAT3 Signaling Pathway
por: Loh, Kenneth C., et al.
Publicado: (2012) -
Author Correction: Inhibitory effects of dopamine receptor D(1) agonist on mammary tumor and bone metastasis
por: Minami, Kazumasa, et al.
Publicado: (2022)